Not applicableWithdrawnNCT01539395What this trial is testingA Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple SclerosisWho this might be right forMultiple Sclerosis MSDx, Inc.
Not applicableEnded earlyNCT02949908What this trial is testingMEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)Who this might be right forMultiple Sclerosis Merck KGaA, Darmstadt, Germany 2
Testing effectiveness (Phase 2)Ended earlyNCT00745615What this trial is testingAn Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the DiseaseWho this might be right forRelapsing Remitting Multiple Sclerosis Teva Pharmaceutical Industries, Ltd. 257
Not applicableUnknownNCT04857489What this trial is testingDeficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple SclerosisWho this might be right forRelapse Remitting Multiple Sclerosis Thomas Jefferson University 80
Not applicableStudy completedNCT00818038What this trial is testingA Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder FunctionWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 30
Large-scale testing (Phase 3)Looking for participantsNCT06700343What this trial is testingComparison Between ABP 692 and Ocrevus® (Ocrelizumab)Who this might be right forRelapsing-remitting Multiple Sclerosis (RRMS) Amgen 444
Not applicableLooking for participantsNCT06389968What this trial is testingLight Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-RemittingOptic Neuritis Technical University of Munich 50
Early research (Phase 1)Study completedNCT01097668What this trial is testingATX-MS-1467 in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forRelapsing Remitting Multiple Sclerosis Apitope Technology (Bristol) Ltd. 43
Testing effectiveness (Phase 2)Study completedNCT01279876What this trial is testingMelatonin in Relapsing-Remitting Multiple Sclerosis PatientsWho this might be right forMultiple Sclerosis, Relapsing-Remitting Tehran University of Medical Sciences 25
Large-scale testing (Phase 3)Study completedNCT01167426What this trial is testingEvaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsWho this might be right forMultiple Sclerosis Teva Neuroscience, Inc. 148
Large-scale testing (Phase 3)WithdrawnNCT00429442What this trial is testingSimvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple SclerosisWho this might be right forRelapsing Remitting Multiple Sclerosis Anna Tsakiri
Early research (Phase 1)UnknownNCT02903537What this trial is testingTolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)Who this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive Fundació Institut Germans Trias i Pujol 16
Not applicableStudy completedNCT04115930What this trial is testingCorrelation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS PatientsWho this might be right forRelapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more University of Eastern Finland 61
Not applicableTemporarily pausedNCT04031469What this trial is testingA Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseWho this might be right forGut MicrobiomeGastrointestinal MicrobiomeAutism+77 more ProgenaBiome 1,000
Not applicableStudy completedNCT01491100What this trial is testingNoninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple SclerosisWho this might be right forMultiple Sclerosis Bayer 1,085
Testing effectiveness (Phase 2)Study completedNCT05691192What this trial is testingCognitive Reserve-building Activities in Multiple SclerosisWho this might be right forMultiple Sclerosis Rigshospitalet, Denmark 60
Not applicableStudy completedNCT05366036What this trial is testingTecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-remitting Eisai Korea Inc. 172
Post-approval studies (Phase 4)UnknownNCT01407211What this trial is testingImpact of Vitamin A on Gene Expression, in Multiple Sclerosis PatientWho this might be right forRelapsing Remitting Multiple Sclerosis Tehran University of Medical Sciences 30
Not applicableStudy completedNCT02159573What this trial is testingReal-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)Who this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 530
Not applicableStudy completedNCT01112345What this trial is testingAn Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These ParametersWho this might be right forMultiple Sclerosis, Relapsing-Remitting Merck KGaA, Darmstadt, Germany 133